LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,089
تعداد مقالات9,995
تعداد مشاهده مقاله26,566,420
تعداد دریافت فایل اصل مقاله7,308,556
Sattarinezhad, Elahe, Panjehshahin, Mohammad Reza, Torabinezhad, Simin, Kamali-Sarvestani, Eskandar, Farjadian, Shirin, Pirsalami, Fatema, Moezi, Leila. (1395). Protective Effect of Edaravone Against Cyclosporine-Induced Chronic Nephropathy Through Antioxidant and Nitric Oxide Modulating Pathways in Rats. سامانه مدیریت نشریات علمی, 42(2), 170-178.
Elahe Sattarinezhad; Mohammad Reza Panjehshahin; Simin Torabinezhad; Eskandar Kamali-Sarvestani; Shirin Farjadian; Fatema Pirsalami; Leila Moezi. "Protective Effect of Edaravone Against Cyclosporine-Induced Chronic Nephropathy Through Antioxidant and Nitric Oxide Modulating Pathways in Rats". سامانه مدیریت نشریات علمی, 42, 2, 1395, 170-178.
Sattarinezhad, Elahe, Panjehshahin, Mohammad Reza, Torabinezhad, Simin, Kamali-Sarvestani, Eskandar, Farjadian, Shirin, Pirsalami, Fatema, Moezi, Leila. (1395). 'Protective Effect of Edaravone Against Cyclosporine-Induced Chronic Nephropathy Through Antioxidant and Nitric Oxide Modulating Pathways in Rats', سامانه مدیریت نشریات علمی, 42(2), pp. 170-178.
Sattarinezhad, Elahe, Panjehshahin, Mohammad Reza, Torabinezhad, Simin, Kamali-Sarvestani, Eskandar, Farjadian, Shirin, Pirsalami, Fatema, Moezi, Leila. Protective Effect of Edaravone Against Cyclosporine-Induced Chronic Nephropathy Through Antioxidant and Nitric Oxide Modulating Pathways in Rats. سامانه مدیریت نشریات علمی, 1395; 42(2): 170-178.

Protective Effect of Edaravone Against Cyclosporine-Induced Chronic Nephropathy Through Antioxidant and Nitric Oxide Modulating Pathways in Rats

Iranian Journal of Medical Sciences
مقاله 7، دوره 42، شماره 2، خرداد 2017، صفحه 170-178    اصل مقاله (838.98 K)
نوع مقاله: Original Article(s)
نویسندگان
Elahe Sattarinezhad1؛ Mohammad Reza Panjehshahin1؛ Simin Torabinezhad2؛ Eskandar Kamali-Sarvestani3؛ Shirin Farjadian4؛ Fatema Pirsalami1؛ Leila Moezi* 5
1Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2Nephrology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
3Autoimmune Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4Department of Immunology, Shiraz University of Medical Sciences, Shiraz, Iran;
5Department of Pharmacology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; and Nanomedicine and Nanobiology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Cyclosporine A (CsA) is an immunosuppressant with therapeutic indications in various immunological diseases; however, its use is associated with chronic nephropathy. Oxidative stress has a crucial role in CsA-induced nephrotoxicity. The present study evaluates the protective effect of edaravone on CsA-induced chronic nephropathy and investigates its antioxidant and nitric oxide modulating property.Methods: Male Sprague-Dawley rats (n=66) were distributed into nine groups, including a control (group 1) (n=7). Eight groups received CsA (15 mg/kg) for 28 days while being treated. The groups were categorized as:Group 2: Vehicle (n=10)Groups 3, 4, and 5: Edaravone (1, 5, and 10 mg/kg) (n=7 each)Group 6: Diphenyliodonium chloride, a specific endothelial nitric oxide synthase (eNOS) inhibitor (n=7)Group 7: Aminoguanidine, a specific inducible nitric oxide synthase (iNOS) inhibitor (n=7)Group 8: Edaravone (10 mg/kg) plus diphenyliodonium chloride (n=7)Group 9: Edaravone (10 mg/kg) plus aminoguanidine (n=7)Blood urea nitrogen and serum creatinine levels, malondialdehyde, superoxide dismutase, and glutathione reductase enzyme activities were measured using standard kits. Renal histopathological evaluations and measurements of eNOS and iNOS gene expressions by RT-PCR were also performed. Data were analyzed using one-way analysis of variance (ANOVA) followed by Tukey’s test (SPSS software version 18.0).Results: Edaravone (10 mg/kg) significantly attenuated CsA-induced oxidative stress, renal dysfunction, and kidney tissue injury. Aminoguanidine improved the renoprotective effect of edaravone. Edaravone reduced the elevated mRNA level of iNOS, but could not alter the level of eNOS mRNA significantly.Conclusion: Edaravone protects against CsA-induced chronic nephropathy using antioxidant property and probably through inhibiting iNOS gene expression.
کلیدواژه‌ها
Edaravone؛ Nitric oxide؛ iNOS؛ eNOSe؛ Kidney diseases؛ Cyclosporine
آمار
تعداد مشاهده مقاله: 2,057
تعداد دریافت فایل اصل مقاله: 937


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب